March 06, 2023 — 06:33 am EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - CTI BioPharma Corp. (CTIC) revealed Loss for fourth quarter that decreased from the same period last year but  missed the Street estimates.
The company's earnings came in at -$17.46 million, or -$0.14 per share.  This compares with -$36.79 million, or -$0.38 per share, in last year's fourth quarter.
Analysts on average had expected the company to earn -$0.10 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
CTI BioPharma Corp. earnings at a glance (GAAP) :
-Earnings (Q4): -$17.46 Mln. vs. -$36.79 Mln. last year.
-EPS (Q4): -$0.14 vs. -$0.38 last year.
-Analyst Estimates: -$0.10
 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.